ACE2 and COVID-19: They are the most commonly described CNS imaging finding in COVID-19 patients [5], and potential mechanisms include endothelial damage linked to the angiotensin-converting enzyme 2 (ACE2) receptor, hypercoagulable state and cardiomyopathy [7].